PharosAI is a platform that integrates artificial intelligence into research and clinical workflows within the NHS, enhancing cancer diagnostics and treatment decision-making through enriched patient datasets. By collaborating with leading healthcare institutions, PharosAI aims to ensure timely and equitable access to personalized care for all patients, regardless of socioeconomic status.
Funding
Funding not disclosed
Founders
Product
Problem
Cancer diagnostics and treatment decisions within healthcare systems like the NHS often rely on incomplete patient datasets, leading to potential delays and inequities in access to personalized care. The integration of comprehensive data and advanced analytical tools into clinical workflows remains a challenge.
Solution
PharosAI aims to improve cancer diagnostics and treatment decision-making by integrating artificial intelligence into research and clinical workflows. The platform enriches patient datasets, providing clinicians with a more complete view of each case. By leveraging AI, PharosAI seeks to facilitate timely and equitable access to personalized care for all patients.
Target Audience
The primary users are healthcare institutions, researchers, and clinicians within the NHS focused on cancer diagnostics and treatment.
Features
- AI-driven analysis of patient data for enhanced diagnostic accuracy
- Integration with existing research and clinical workflows
- Enriched patient datasets for comprehensive case evaluation